本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Oncolytics Biotech Inc

0.9235
-0.0238-2.51%
盤後0.92350.00000.00%16:10 EDT
成交量:39.16萬
成交額:36.29萬
市值:9,973.80萬
市盈率:-3.23
高:0.9500
開:0.9340
低:0.9123
收:0.9473
52周最高:1.51
52周最低:0.3258
股本:1.08億
流通股本:1.06億
量比:0.73
換手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):-0.2855
每股收益(LYR):-0.2881
淨資產收益率:-769.06%
總資產收益率:-111.21%
市淨率:1193.76
市盈率(LYR):-3.20

資料載入中...

2026/03/20

重要事件披露

Form 8-K - Current report
2026/03/19

重要事件披露

Form 8-K - Current report
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/04

重要事件披露

Form 8-K - Current report
2026/01/15

重要事件披露

Form 8-K - Current report
2026/01/15

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/09

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/08/28

SEC問詢函

Form CORRESP - Correspondence
2025/03/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/05

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/24

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]